The consolidator trading as Meridian Freight Partners closes after 10 years
A proper account of an operation that existed, and of what closing it cost.
The archive — 2026
Page 19 of 34 of this archive, newest first.
What a 31% rise in coupling-reagent prices does to a 2 mg vial
Follow the resin, not the catalogue.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
Nought point nine eight of a dalton: the modification that hides in plain sight
What would be needed to catch each of these, and what it would cost.
The upper rungs, ranked by evidence
Where the curve flattens, what flattens with it, and what does not.
The online reseller trading as Adamant Research Supply enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
Japan health authority warns on falsified tirzepatide pens
Reported from the analysis, not from a warning notice.
LEADER misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
What a month without the drug does to tolerability
Concentrations fall by half a week, so a month away leaves a small fraction of steady state. Resuming at the previous dose presents the receptor with a step it has not seen…
The advice is mostly reasonable. The certainty is not earned.
The gap between a defensible recommendation and a confident one is where most of the harm in this subject lives.
From the floor in Xianning: 14 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
What a 17% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
A supplier suspends shipping to Saudi Arabia after 15 consecutive customs detentions
The route did not close because of a rule about peptides.
Pancreatitis, obstruction, gallbladder: three things nausea can be
Rapid weight loss by any means raises gallstone risk. Separating that from a direct drug effect requires a comparator, and the trials have one.
Low endotoxin recovery: the interference nobody looks for
The limit for a parenteral product is calculable from the dose and the body weight in two lines. Almost nobody in this trade performs the calculation.
Spain health authority warns on falsified exenatide pens
Reported from the analysis, not from a warning notice.
From the floor in Changsha: 23 posters, one theme
Reported from the sessions, and from the two hours afterwards.
The 16-day notice: how a compounding wind-down works in France
The document is four pages. Three of them are about dates.
What the new Poland guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What happens to a stopper after the fourth needle
Particulate matter is the oldest quality attribute in injectable manufacture and the one a private buyer is best placed to assess without instrumentation.
Lipohypertrophy, and the absorption it ruins
Repeated injection into the same small area produces lipohypertrophy — thickened, rubbery subcutaneous tissue with blunted and erratic absorption. It is common, it is…
The interventions with trial support, and the much longer list without
Almost nothing in the standard management repertoire has been tested in a randomised trial in this specific population. We say what is extrapolated and from where.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
A shortage listing ends. 16 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
SURMOUNT-OSA misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
A design note on withdrawal trials, and why the run-in matters
The evidence on stopping is better than the evidence on almost anything else in this field, because somebody deliberately randomised it.
From the floor in Hangzhou: 5 posters, one theme
Reported from the sessions, and from the two hours afterwards.
What the new Ireland guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What a 32% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.